Amdocs (NASDAQ:DOX – Get Free Report) issued its earnings results on Wednesday. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01, FiscalAI reports. The firm had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.17 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.78 earnings per share. Amdocs updated its FY 2026 guidance to 7.340-7.480 EPS and its Q3 2026 guidance to 1.810-1.870 EPS.
Here are the key takeaways from Amdocs’ conference call:
- Amdocs reported a solid Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both above the midpoint of guidance, with year-over-year growth in North America and record revenue in Europe.
- The company secured several meaningful contract wins and extensions, including expanded managed services with Cricket Wireless, a 5-year CRM/OSS modernization deal with Vodafone Spain, and a multi-year charging system extension with KT.
- Amdocs said its new aOS agentic operating system is getting early traction, with initial commercial agreements from Cricket, Lumen, Bell Canada, EchoStar, and PLDT; PLDT is already seeing over 90% of customer requests resolved through the platform.
- Management reiterated full-year fiscal 2026 guidance, including 3% constant-currency revenue growth at the midpoint and roughly 6% non-GAAP EPS growth, while noting it is still monitoring customer spending amid macro uncertainty.
- Cash generation remained strong, with $97 million in free cash flow before restructuring in Q2 and the company on track for $710 million to $730 million for fiscal 2026, supporting continued shareholder returns and liquidity.
Amdocs Stock Performance
NASDAQ DOX traded down $2.41 during trading hours on Wednesday, hitting $59.93. The company had a trading volume of 1,810,046 shares, compared to its average volume of 953,890. The business has a 50 day moving average of $65.54 and a 200-day moving average of $73.80. The company has a market cap of $6.47 billion, a PE ratio of 11.59, a price-to-earnings-growth ratio of 1.10 and a beta of 0.40. Amdocs has a 1-year low of $59.40 and a 1-year high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06.
Institutional Trading of Amdocs
Amdocs News Summary
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Amdocs reported fiscal Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both slightly ahead of estimates, which suggests steady demand and execution. Amdocs Limited Reports Second Quarter Fiscal 2026 Results
- Positive Sentiment: The company secured several new and expanded customer wins, including agreements with Telefónica Móviles Argentina, Vodafone Ireland, Lumen Technologies, and Qué tal Móvil, which support its recurring revenue base and long-term backlog. Telefónica Móviles Argentina Signs Strategic Multi-Year Agreement with Amdocs to Advance its Operational Excellence
- Positive Sentiment: Amdocs also highlighted new AI and cloud-related announcements, including Telco Agents in Google’s Gemini Enterprise marketplace and a benchmark performance milestone for its Entitlement Server on Microsoft Azure, reinforcing its positioning in telecom software modernization. Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure
- Neutral Sentiment: Management nudged full-year fiscal 2026 revenue and EPS guidance slightly, but the updated outlook appears broadly consistent with Wall Street expectations, limiting the stock’s immediate upside. Amdocs (DOX) Tops Q2 Earnings and Revenue Estimates
- Negative Sentiment: The company announced that long-time CFO Tamar Rapaport-Dagim will retire, with an internal successor taking over in June, and investors may view the leadership change as an added uncertainty near term. Amdocs Limited Reports Second Quarter Fiscal 2026 Results
Wall Street Analyst Weigh In
DOX has been the subject of several analyst reports. Stifel Nicolaus lowered their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, April 18th. Barclays decreased their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, February 4th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $92.33.
View Our Latest Report on Amdocs
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Stories
- Five stocks we like better than Amdocs
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
